Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China

Hemoglobin

Volumn 40, Issue 5, 2016, Pages 304-309

  Ding, Zhong Ying ^a   Shen, Guo Song ^a   Zhang, Su ^a   He, Ping Ya ^a  

^a Huzhou Maternal and Child Care Hospital   (China)

Author keywords

Capillary electrophoresis (CE); hemoglobin (Hb); high resolution melting analysis (HRM); iron deficiency; thalassemia; variant

Indexed keywords

FERRITIN; HEMOGLOBIN; HEMOGLOBIN A1C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN S; HEMOGLOBIN VARIANT; IRON;

ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; CAPILLARY ELECTROPHORESIS; CHINA; CODON; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR VOLUME; PREDICTIVE VALUE; PREGNANT WOMAN; PREVALENCE; RED BLOOD CELL DISTRIBUTION WIDTH; SENSITIVITY AND SPECIFICITY; THALASSEMIA; ALPHA-THALASSEMIA; BETA-THALASSEMIA; DEFICIENCY; GENETICS; HEMOGLOBINOPATHIES; HETEROZYGOTE; MOLECULAR EPIDEMIOLOGY; PREGNANCY;

ALPHA-THALASSEMIA; BETA-THALASSEMIA; BLOOD CELL COUNT; CHINA; FEMALE; GENE FREQUENCY; HEMOGLOBINOPATHIES; HEMOGLOBINS, ABNORMAL; HETEROZYGOTE; HUMANS; IRON; MOLECULAR EPIDEMIOLOGY; PREGNANCY; PREVALENCE;

EID: 84987624360     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630269.2016.1200988     Document Type: Article

References (23)

1. T.N.Williams, D.J.Weatherall World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9):a011692 doi:10.1101/cshperspect.a011692.
2. B.Giardine, J.Borg, E.Viennas,. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
3. S.F.Fonseca, J.P.MouraNeto, M.S.Goncalves Prevalence and molecular characterization of β-thalassemia in the state of Bahia, Brazil:First identification of mutation HBB:c.135delC in Brazil. Hemoglobin. 2013;37(3):285–290.
4. B.Modell, M.Darlison Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
5. D.J.Weatherall Hemoglobinopathies worldwide:Present and future. Curr Mol Med. 2008;8(7):592–599.
6. D.J.Weatherall, J.B.Clegg The Thalassaemia Syndromes, 4th ed. Oxford, UK:Blackwell Science, 2001.
7. D.Rund, E.Rachmilewitz. β-thalassemia. N Engl J Med. 2005;353(11):1135–1146.
8. C.G.Li, C.F.Li, Q.Li, M.Li Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong Province. Hemoglobin. 2009;33(5):296–303.
9. N.R.van den Broek, E.A.Letsky, S.A.White, A.Shenkin Iron status in pregnant women:Which measurements are valid. Br J Haematol. 1998;103(3):817–824.
10. S.Blackmore, M.Hamilton, A.Lee,. Automated immunoassay methods for ferritin:recovery studies to assess traceability to an international standard. Clin Chem Lab Med. 2008;46(10):1450–1457.
11. G.Perrota Iron and iron-binding capacity. In:A.J.Pesce, L.A.Kaplan, Eds. Methods in Clinical Chemistry. St. Louis, MO, USA:C.V. Mosby. 1987:1258–1261.
12. Z.Yang, C.H.Chaffin, P.L.Easley,. Prevalence of elevated Hemoglobin A2 measured by the CAPILLARYS system. Am J Clin Pathol. 2009;131(1):42–48.
13. J.P.Landers Clinical capillary electrophoresis. Clin Chem. 1995;41(4):495–509.
14. S.Pornprasert, S.Panyasai, K.Treesuwan. Unmasking Hb Paksé (codon 142, TAA>TAT, α2) and its combinations in patients also carrying Hb Constant Spring (codon 142, TAA>CAA, α2) in northern Thailand. Hemoglobin. 2012;36(5):491–496.
15. X.He, M.Sheng, M.Xu,. Rapid identification of common β-thalassemia mutations in the Chinese population using duplex or triplex amplicon genotyping by high-resolution melting analysis. Genet Test Mol Biomarkers. 2010;14(6):851–856.
16. H.G.Shih, T.K.Er, T.J.Chang,. Rapid identification of HBB gene mutations by high-resolution melting analysis. Clin Biochem. 2009;42(16-17):1667–1676.
17. M.Lin, T.Y.Zhong, Y.G.Chen,. Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P. R. China. PLoS One. 2014;9(7):e101505. doi:10.1371/journal.pone.0101505.
18. F.Xiong, M.Sun, X.Zhang,. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
19. X.M.Xu, Y.Q.Zhou, G.X.Luo,. The prevalence and spectrum of α and β thalassaemia in Guangdong Province:implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
20. S.-R.Pasricha, H.Drakesmith, J.Black,. Control of iron deficiency anemia in low- and middle-income countries. Blood. 2013;121(14):2607–2617.
21. M.Usman, M.Moinuddin, S.A.Ahmed. Role of iron deficiency anemia in the propagation of β thalssemia gene. Korean J Hematol. 2011;46(1):41–44.
22. K.J.Behan, N.M.Storey, H.K.Lee Reporting variant hemoglobins discovered during Hemoglobin A1c analysis – Common practices in clinical laboratories. Clin Chim Acta. 2009;406(1-2):124–128.
23. K.R.Rosenbloom, C.A.Sloan, V.S.Malladi,. PhenCode:Connecting ENCODE data with mutations and phenotype. Hum Mutat. 2007;28(6):554–562.